首页> 美国卫生研究院文献>BMB Reports >The origin-of-cell harboring cancer-driving mutations in human glioblastoma
【2h】

The origin-of-cell harboring cancer-driving mutations in human glioblastoma

机译:人胶质母细胞瘤中具有癌症驱动突变的细胞起源

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Glioblastoma (GBM) is the most common and aggressive form of human adult brain malignancy. The identification of the cell of origin harboring cancer-driver mutations is the fundamental issue for understanding the nature of GBM and developing the effective therapeutic target. It has been a long-term hypothesis that neural stem cells in the subventricular zone (SVZ) might be the origin-of-cells in human glioblastoma since they are known to have life-long proliferative activity and acquire somatic mutations. However, the cell of origin for GBM remains controversial due to lack of direct evidence thereof in human GBM. Our recent study using various sequencing techniques in triple matched samples such as tumor-free SVZ, tumor, and normal tissues from human patients identified the clonal relationship of driver mutations between GBM and tumor-free SVZ harboring neural stem cells (NSCs). Tumor-free SVZ tissue away from the tumor contained low-level GBM driver mutations (as low as 1% allelic frequency) that were found in the dominant clones in its matching tumors. Moreover, via single-cell sequencing and microdissection, it was discovered that astrocyte-like NSCs accumulating driver mutations evolved into GBM with clonal expansion. Furthermore, mutagenesis of cancer-driving genes of NSCs in mice leads to migration of mutant cells from SVZ to distant brain and development of high-grade glioma through the aberrant growth of oligodendrocyte precursor lineage. Altogether, the present study provides the first direct evidence that NSCs in human SVZ is the cell of origin that develops the driver mutations of GBM.
机译:胶质母细胞瘤(GBM)是成人脑恶性肿瘤的最常见和侵略性形式。鉴定具有癌症驱动基因突变的起源细胞是了解GBM的本质和开发有效治疗靶标的根本问题。长期存在的假设是,脑室下区域(SVZ)中的神经干细胞可能是人胶质母细胞瘤中的细胞起源,因为已知它们具有终生增殖活性并获得体细胞突变。然而,由于缺乏在人类GBM中的直接证据,GBM的起源细胞仍存在争议。我们最近的研究使用了多种测序技术,对三重匹配的样本(例如无肿瘤的SVZ,肿瘤和人类患者的正常组织)进行了鉴定,确定了GBM和具有神经干细胞(NSC)的无肿瘤的SVZ之间的驱动突变。远离肿瘤的无肿瘤SVZ组织包含低水平的GBM驱动程序突变(低至1%等位基因频率),该突变在其匹配肿瘤的显性克隆中发现。此外,通过单细胞测序和显微解剖,发现积累驱动子突变的星形胶质样NSCs随克隆扩增而进化为GBM。此外,小鼠中NSCs的癌症驱动基因的诱变会导致突变细胞从SVZ迁移到遥远的大脑,并通过少突胶质细胞前体谱系的异常生长而发展为高级神经胶质瘤。总而言之,本研究提供了第一个直接证据,表明人SVZ中的NSC是产生GBM驱动程序突变的起源细胞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号